Institutional Repository
Technical University of Crete
EN  |  EL

Search

Browse

My Space

Dynamic spectral imaging: improving colposcopy

Balas Costas, Soutter WP1, Diakomanolis E, Lyons D, Ghaem-Maghami S, Ajala T, Haidopoulos D, Doumplis D, Kalpaktsoglou C, Sakellaropoulos G, Soliman S, Perryman K, Hird V, Buckley CH, Pavlakis K, Markaki S, Dina R, Healy V,

Full record


URI: http://purl.tuc.gr/dl/dias/14410D7E-563E-4ABC-8379-3260167C8F80
Year 2015
Type of Item Peer-Reviewed Journal Publication
License
Details
Bibliographic Citation Soutter WP1, Diakomanolis E, Lyons D, Ghaem-Maghami S, Ajala T, Haidopoulos D, Doumplis D, Kalpaktsoglou C, Sakellaropoulos G, Soliman S, Perryman K, Hird V, Buckley CH, Pavlakis K, Markaki S, Dina R, Healy V, Balas C., "Dynamic spectral imaging: improving colposcopy." Clinical Cancer Research, 2009 Mar. Vol. 15, Iss. 5, pp. 814-20, doi: 10.1158/1078-0432 https://doi.org/10.1158/1078-0432.CCR-08-1636
Appears in Collections

Summary

PURPOSE:Colposcopy occupies a key role in the prevention of cervical cancer by identifying preinvasive or invasive lesions. However, colposcopy is subjective and is responsible for 52% of screening failures. Dynamic spectral imaging (DSI) is based on the objective, quantitative assessment of the acetowhitening effect. This study compared DSI with colposcopy.EXPERIMENTAL DESIGN:Women referred for colposcopy were examined simultaneously with colposcopy and DSI using a precommercial DySIS model (FPC-03) in an international, multicenter trial. The colposcopy impression and DySIS values were compared with consensus histology reports of biopsies. Subjects were recruited to a training group and subsequently to a test group. Measures were taken to avoid verification bias.RESULTS:The training and test groups comprised 82 and 308 eligible women, respectively. A cutoff value to identify high-grade disease was selected from the results of the training group and data from previous work. Receiver operator curve analysis of the test data showed an area under the curve of 0.844. DySIS detected 62.9% more high-grade cases than colposcopy (57 versus 35, P=0.0001). DySIS exceeded end points approved by the Food and Drug Administration for similar studies, with increments in the true positive rate of 22/308 (7.1%; lower 95% CL, 4.5% versus 2%) and in the false positive rate of 32/308 (10.4%; upper 95% CL, 14.7% versus 15%).CONCLUSIONS:DySIS is more sensitive than colposcopy in detecting high-grade lesions and can provide improved guidance for biopsy. The results are obtained in a user-independent fashion, making it suitable for use by nursing personnel.

Services

Statistics